Frecuencia Alélica Y Genotipica De Hla-B Y Hla-B*27 En Un Grupo De Individuos Sanos En Colombia
Varios de los genes de la respuesta inmune se encuentran en el complejo mayor de histocompatibilidad (MHC). El sistema de antígenos de leucocitos humanos (HLA) es un conjunto de moléculas de superficie de células altamente polimórficas que se unen a péptidos derivados del procesamiento antigénico co...
- Autores:
-
Hernández Bocanegra, Natalia Andrea
- Tipo de recurso:
- Trabajo de grado de pregrado
- Fecha de publicación:
- 2019
- Institución:
- Colegio Mayor de Cundinamarca
- Repositorio:
- Repositorio Colegio Mayor de Cundinamarca
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.unicolmayor.edu.co:unicolmayor/3698
- Acceso en línea:
- https://repositorio.unicolmayor.edu.co/handle/unicolmayor/3698
- Palabra clave:
- frecuencia genotípica
sistema LUMINEX IS 100/200
HLA-B
HLA-B*27
frecuencia alélica
- Rights
- closedAccess
- License
- Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2019
id |
UCOLMAYOR2_ccc26e1a38cc7673cefc06e400feda2f |
---|---|
oai_identifier_str |
oai:repositorio.unicolmayor.edu.co:unicolmayor/3698 |
network_acronym_str |
UCOLMAYOR2 |
network_name_str |
Repositorio Colegio Mayor de Cundinamarca |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Frecuencia Alélica Y Genotipica De Hla-B Y Hla-B*27 En Un Grupo De Individuos Sanos En Colombia |
title |
Frecuencia Alélica Y Genotipica De Hla-B Y Hla-B*27 En Un Grupo De Individuos Sanos En Colombia |
spellingShingle |
Frecuencia Alélica Y Genotipica De Hla-B Y Hla-B*27 En Un Grupo De Individuos Sanos En Colombia frecuencia genotípica sistema LUMINEX IS 100/200 HLA-B HLA-B*27 frecuencia alélica |
title_short |
Frecuencia Alélica Y Genotipica De Hla-B Y Hla-B*27 En Un Grupo De Individuos Sanos En Colombia |
title_full |
Frecuencia Alélica Y Genotipica De Hla-B Y Hla-B*27 En Un Grupo De Individuos Sanos En Colombia |
title_fullStr |
Frecuencia Alélica Y Genotipica De Hla-B Y Hla-B*27 En Un Grupo De Individuos Sanos En Colombia |
title_full_unstemmed |
Frecuencia Alélica Y Genotipica De Hla-B Y Hla-B*27 En Un Grupo De Individuos Sanos En Colombia |
title_sort |
Frecuencia Alélica Y Genotipica De Hla-B Y Hla-B*27 En Un Grupo De Individuos Sanos En Colombia |
dc.creator.fl_str_mv |
Hernández Bocanegra, Natalia Andrea |
dc.contributor.advisor.none.fl_str_mv |
Romero Sánchez, María Consuelo Chila Moreno, Leidy Lorena Infante Cruz, Alejandra Del Pilar |
dc.contributor.author.none.fl_str_mv |
Hernández Bocanegra, Natalia Andrea |
dc.subject.lemb.none.fl_str_mv |
frecuencia genotípica sistema LUMINEX IS 100/200 |
topic |
frecuencia genotípica sistema LUMINEX IS 100/200 HLA-B HLA-B*27 frecuencia alélica |
dc.subject.proposal.spa.fl_str_mv |
HLA-B HLA-B*27 frecuencia alélica |
description |
Varios de los genes de la respuesta inmune se encuentran en el complejo mayor de histocompatibilidad (MHC). El sistema de antígenos de leucocitos humanos (HLA) es un conjunto de moléculas de superficie de células altamente polimórficas que se unen a péptidos derivados del procesamiento antigénico con la finalidad de presentárselos a los linfocitos T, para inducir su activación y función efectora. Dentro de los alelos de clase I se encuentran el HLA-B y su subtipo HLA-B*27 que está altamente asociado con la presencia de enfermedades musculo esqueléticas. El objetivo de este proyecto de investigación es la caracterización de los genotipos y alelos HLA-B y su subtipo B*27 específicamente en una población de individuos sanos colombianos y así evidenciar la variabilidad genética producto del mestizaje. La muestra comprendió 255 individuos sanos, sin clínica sugestiva de enfermedades reumáticas, remitidos al laboratorio de Inmunología del Hospital Militar Central desde el año 2015 al 2018 con solicitud de tipificación HLA- A, B, DR por sistema molecular SSO- LUMINEX IS 100/200. Los resultados mostraron 27 genotipos y 89 alelos HLA-B, así mismo, trece sujetos fueron positivos para el antígeno B*27 correspondientes a los alelos más frecuentemente reportados en población colombiana y latinoamericana. |
publishDate |
2019 |
dc.date.issued.none.fl_str_mv |
2019-06 |
dc.date.accessioned.none.fl_str_mv |
2021-11-22T01:48:22Z |
dc.date.available.none.fl_str_mv |
2021-11-22T01:48:22Z |
dc.type.spa.fl_str_mv |
Trabajo de grado - Pregrado |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_7a1f |
dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.content.spa.fl_str_mv |
Text |
dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/TP |
dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
http://purl.org/coar/resource_type/c_7a1f |
status_str |
publishedVersion |
dc.identifier.uri.none.fl_str_mv |
https://repositorio.unicolmayor.edu.co/handle/unicolmayor/3698 |
dc.identifier.barcode.none.fl_str_mv |
60085 |
url |
https://repositorio.unicolmayor.edu.co/handle/unicolmayor/3698 |
identifier_str_mv |
60085 |
dc.language.iso.spa.fl_str_mv |
spa |
language |
spa |
dc.relation.references.spa.fl_str_mv |
Abbas A k, Lichtman AH, Pillai shiv. Inmulogía celular y molecular. 8va ed. España: Elsevier saunders; 2015. 110–130 p. Bermeo S, Guerra MT, Alfonso HO. Frecuencias de HLA-A, B y DRB1 en una población de Huila-Colombia. Rev Fac Salud - RFS. 2015;2(1):9–19. Arrunategui AM, Villegas A, Ocampo LÁ, Rodríguez LM, Badih A. Frecuencias alélicas, genotípicas y haplotípicas del sistema HLA clase I y II en donantes de una población del suroccidente colombiano. Acta Medica Colomb [Internet]. 2013;38(1):16–21. Ossa H, Aquino J, Pereira R, Ibarra A, Ossa RH, Pérez LA, et al. Outlining the ancestry landscape of Colombian admixed populations. PLoS One. 2016;11(10):1– 15. López de Castro JA. HLA-B27 y patogenia de las espondiloartropatías. Reumatol Clínica. 2009;3:S24–8. OMS C de N de la. IPD-IMGT / HLA [Internet]. IPD-IMGT / HLA. 2019. Oguz FS, Ocal L, Diler AS, Ozkul H, Asicioglu F, Kasapoglu E, et al. HLA B-27 subtypes in turkish patients with spondyloarthropathy and healthy controls. Dis Markers. 2004;20(6):309–12. Sanchez-Mazas A, Nunes JM, Middleton D, Sauter J, Buhler S, McCabe A, et al. Common and well-documented HLA alleles over all of Europe and within European sub-regions: A catalogue from the European Federation for Immunogenetics. HLA. 2017;89(2):104–13. Martínez Julio, Navarrete Ana, Arrazola Araceli, Suárez América Z-NA, Camargo Adolfo , García Beatriz RR, Ambriz Raúl JJ. Subtipos de HLA-B27 en familias de pacientes mestizos mexicanos con espondilitis anquilosante. Asoc Mex Med Transfusional, AC [Internet]. 2008;1(1):18–22. Chila M L, Romero Sánchez C, Gómez G A, Casas M, Bautista Molano W, Maldonado Z, et al. Métodos para la identificación del antígeno de histocompatibilidad HLA-B27: comparación de cuatro protocolos técnicos. Rev Med [Internet]. 2015;23(1):22. Duangchanchot M, Puapairoj C, Romphruk A, Kongmaroeng C, Leelayuwat C, 54 Romphruk A V. HLA-B*27 subtypes in Northern and Northeastern Thais, Karens, and Bamars determined by a high-resolution PCR-SSP technique. Tissue Antigens. 2009;73(6):590–4. Rodríguez LM, Giraldo MC, García N, Velásquez L, París SC, Álvarez CM, et al. Frecuencias alélicas, genotípicas y haplotípicas HLA-A, HLA-B, HLA-DRB1 en donantes fallecidos, Medellín, Colombia. Biomédica [Internet]. 2007;27(4):537. Pozzi S, Longo A, Ferrara GB. HLA-B locus sequence-based typing. Tissue Antigens. 1999;53(3):275–81. Paradoa ML, Middleton D, Acosta A, Sarmiento ME, Leyva J. Genes HLA en una muestra de la población cubana. Vaccimonitor. 2000;(3):3–7. Caraballo LR, Marrugo GJ, Erlich CH, Mildred Pastorizo L. HLA alleles in the population of Cartagena (Colombia). Tissue Antigens. 1992;39(3):128–33. 16. Bengochea M, Salzano EM. I . Alvarez M . Sans R . Toledo M . Sosa HLA Gene and Haplotype Frequencies in Uruguay. 1993;8:163–4. Infante E, Olivo A, Alaez C, Williams F, Middleton D, De la Rosa G, et al. Molecular analysis of HLA class I alleles in the Mexican Seri Indians: Implications for their origin. Tissue Antigens. 1999;54(1):35–42. Williams F, Meenagh A, Darke C, Acosta A, Daar AS, Gorodezky C, et al. Analysis of the distribution of HLA-B alleles in populations from five continents. Hum Immunol. 2001;62(6):645–50. D. Middleton, F. Williams, A. Meenagh, A. S. Daar, C. Gorodezky, M. Hammond, E. Nascimento I. Briceno and MPP. Analysis of the Distribution of HLA-A Alleles in Populations from Five Continents. Management. 2000;61(00):1048–52. Alfaro EL, Dipierri JE, Gutiérrez N, Vullo CM. Frecuencias génicas y haplotípicas del sistema HLA en el Noroeste argentino. Antropo. 2004;6(June 2014):15–23. Pédron B, Yakouben K, Guérin V, Borsali E, Auvrignon A, Landman J, et al. HLA Alleles and Haplotypes in French North African Immigrants. Hum Immunol. 2006;67(7):540–50. Zhang HB, Wei SG, Zheng HB, Yu B, Lai JH. Distribution of human leukocyte antigen alleles and haplotypes in Oroqen and Ewenki nationality minority in Inner Mongolia Autonomous Region of China. Int J Immunogenet. 2010;37(5):337–44. Acar M, Cora T, Tunc R, Acar H. HLA-B27 subtypes in Turkish patients with ankylosing spondylitis and healthy controls. Rheumatol Int. 2012;32(10):3103–5. Hajeer AH, Al Balwi MA, Ayt??l Uyar F, Alhaidan Y, Alabdulrahman A, Al Abdulkareem I, et al. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in Saudis using next generation sequencing technique. Tissue Antigens. 2013;82(4):252–8. Andric Z, Popadic D, Jovanovic B, Jaglicic I, Bojic S, Simonovic R. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in the Serbian population. Hum Immunol [Internet]. 2014;75(3):218–26. Kongmaroeng C, Romphruk A, Puapairoj C, Leelayuwat C, Kulski JK, Inoko H, et al. HLA alleles and haplotypes in Burmese (Myanmarese) and Karen in Thailand. Tissue Antigens. 2015;86(3):199–204. Sulcebe G, Shyti E. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in a population of 432 healthy unrelated individuals from Albania. Hum Immunol [Internet]. 2016;77(8):620–1. Esmaeili AR, Zamani Taghizadeh Rabe S, Mahmoudi M, Rastin M. Frequencies of HLA-A, B and DRB1 alleles in a large normal population living in the city of mashhad, northeastern Iran. Iran J Basic Med Sci. 2017;20(8):940–3. Loubser S, Paximadis M, Tiemessen CT. Human leukocyte antigen class I (A, B and C) allele and haplotype variation in a South African Mixed ancestry population. Hum Immunol [Internet]. 2017;78(5–6):399–400. Weiskopf D, Grifoni A, Arlehamn CSL, Angelo M, Leary S, Sidney J, et al. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 339 adults from Managua, Nicaragua. Hum Immunol [Internet]. 2018;79(1):1–2. Arnaiz-Villena A, Bayona B, Palacio-Gruber J, Hernández E, Muñiz E, Campos C, et al. HLA genes in Barranquilla (North Colombia): Searching for cryptic Amerindian genes. Hum Immunol [Internet]. 2018;79(1):3–4. Páez-Gutiérrez IA, Hernández-Mejía DG, Vanegas D, Camacho-Rodríguez B, Perdomo-Arciniegas AM. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies of 1463 umbilical cord blood units typed in high resolution from Bogotá Colombia. Hum Immunol [Internet]. 2019;6–11. Murphy Kenneth, Travers Paul WM. Inmunobiología de Janeway. 2009. 197–205 p. Martínez-Borra J, López-Larrea C. The emergence of the Major Histocompatilibility Complex. Adv Exp Med Biol. 2012;738:277–89. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of the extended human MHC. Nat Rev Genet. 2004;5(12):889–99. Frank Christiansen BD. The major histocompatibility Complex: A paradigm for studies of the Human Genome. In: Immunogenetics: Methods and Applications in Clinical Practice [Internet]. 2012. p. 133–59. Claas FH, Duquesnoy RJ. The polymorphic alloimmune response in clinical transplantation. Curr Opin Immunol. 2008;20(5):566–7. Walsh EC, Stevens CR, Rioux JD, Goyette P, Vyse TJ, Fernando MMA, et al. Defining the Role of the MHC in Autoimmunity: A Review and Pooled Analysis. PLoS Genet. 2008;4(4):e1000024. Goddard CA, Butts DA, Shatz CJ. Regulation of CNS synapses by neuronal MHC class I. Proc Natl Acad Sci. 2007;104(16):6828–33. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens. 2004;64(6):631–49. Beck S, Trowsdale J. the human major histocompatibility c omplex : Lessons from the DNA Sequence . Annu Rev Genomics Hum Genet. 2002;1(1):117–37. Centro Nacional de Información de Ciencias Médicas. CR, Morera Barrios LM, García García M de los A. Revista cubana de hematología inmunología y hemoterapia. [Internet]. Vol. 23, Revista Cubana de Hematología, Inmunología y Hemoterapia. Centro Nacional de Información de Ciencias Medicas, Ministerio de Salud Publica; 2007 [cited 2018 Oct 29]. 0–0 p. Sung C. The HLA System: Genetics, Immunology, Clinical Testing, and Clinical Implications. Yonsei Med J. 2007;48(1):11–23. Bjorkman PJ, Parham P. structure, function, and dive1rsity of class i major histOcompatibility complex molecules. 1990; Bjorman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL WD. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987;506:506–512. An J, Lein K, Kie A, Ato S. Review Articles Advances in Immunology First of Two Parts. 2000; Available from: www.nejm.org Engelhard VH. Structure of Peptides Associated with Class I and Class II MHC Molecules. Annu Rev Immunol. 2003;12(1):181–207. Sampson C. Peptide Binding for Class I and Class II MHC Molecules. 2015;281– 302. Blum J, Wearsch P, Cresswell P. Pathways of antigen processing. Annu Rev Immunol. 2013. 443–473 p. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, et al. MHC Molecule HLA-A2 . 1 by Mass Spectrometry. Science (80- ). 1992;255:1–4. Zimmerman SB. The three-dimensional structure of DNA. Ann Rev Biochem. 1982;51:395–427. Watts C. Capture and Processing of Exogenous Antigens for Presentation on Mhc Molecules. Annu Rev Immunol [Internet]. 1997;15(1):821–50. Wearsch PA, Cresswell P. The quality control of MHC class I peptide loading. Curr Opin Cell Biol. 2008;20(6):624–31. Cascio P, Hilton C, Kisselev AF, Rock KL, Goldberg AL. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 2001;20(10):2357–66. Nguyen TT, Chang S, Evnouchidou I, York IA, Zikos C. NIH Public Access. Nat Struct Mol Biol. 2011;18(5):604–13. Vigneron N, Ferrari V, Stroobant V, Habib JA, Van Den Eynde BJ. Peptide splicing by the proteasome. J Biol Chem. 2017;292(51):21170–9. Yewdell JW. DRiPs Solidify: Progress in Understanding Endogenous MHC Class I Antigen Processing. 2011;32(11):548–58. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schröter F, et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell. 2010;142(4):613–24. Zarling AL, Luckey CJ, Marto JA, White FM, Brame CJ, Evans AM, et al. Tapasin Is a Facilitator, Not an Editor, of Class I MHC Peptide Binding. J Immunol [Internet]. 2003;171(10):5287–95. Concha-benavente F, Srivastava R, Ferrone S, Robert L, Hospital MG, Program I. Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells. 2017;52–8. Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature. 2002;419(6906):480– 3. Saveanu L, Carroll O, Lindo V, Del Val M, Lopez D, Lepelletier Y, et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol. 2005;6(7):689–97. Painter CA, Stern LJ. Conformational variation in structures of classical and non- classical MHCII proteins and functional implications. Immunol Rev. 2012;250(1):144–57. Anders AK, Call MJ, Schulze MSED, Fowler KD, Schubert DA, Seth NP, et al. HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat Immunol [Internet]. 2011;12(1):54–61. R. B, C.H. R, S. R, A.W. L, J.J. H, T. B, et al. Achieving stability through editing and chaperoning: Regulation of MHC class II peptide binding and expression. Immunol Rev [Internet]. 2005;207:242–60. Watts C. The endosome-lysosome pathway and information generation in the immune system. Biochim Biophys Acta - Proteins Proteomics [Internet]. 2012;1824(1):14–21. Vyas Jatin, Van der Veen Annemarthe P hidde. The known unknowns of antigen processing and presentation. 2008;8(8):607–18. Cresswell P. Invariant chain structure and MHC class II function. Cell. 1996;84(4):505–7. Piner valérie, Vergelli Marco, Martin Roland, Oddmund BAkke LE. Antigen presentation mediated by recyling of surface HLA- DR molecules. In 1995. p. 603– 6. Ghosh Partho, Amaya Miguel, Mellins Elizabeth WD. The strucutre of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Natur. 1995;378:457–62. Pos W, Sethi DK, Call MJ, Schulze MED, Anders A, Pyrdol J. Crystal Structure of the HLA-DM – HLA-DR1 Complex Defines Mechanisms for Rapid Peptide Selection. Cell [Internet]. 2012;151(7):1557–68. Castiblanco J, Anaya J-M. Genetics and Vaccines in the Era of Personalized Medicine. Curr Genomics. 2015;16(1):47–59. Maffei A, Harris PE. Peptides bound to major histocompatibility complex molecules. Peptides. 1998;19(1):179–98. Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, et al. Supporting Online Material for Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity. Publ Sci [Internet]. 2008;322(5904):1097–100. Heath WR, Carbone FR, Walter T, Hall E, Royal PO. Cross-presentation in viral immunity and self-tolerance. 2001;1(November):126–35. Kumar KS, Duesbery MS, Louat NP, Provenzano V, DiPietro MS. Microporous fine-grained copper: Structure and properties. Philos Mag A Phys Condens Matter, Struct Defects Mech Prop. 2001;81(5):1023–40. Queiro R, Morante I, Cabezas I, Acasuso B. HLA-B27 and psoriatic disease: A modern view of an old relationship. Rheumatol (United Kingdom). 2015;55(2):221– 9. Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2015;45(7):730–8. Asquith M, Elewaut D, Lin P, Rosenbaum JT. The role of the gut and microbes in the pathogenesis of spondyloarthritis. Best Pract Res Clin Rheumatol [Internet]. 2014;28(5):687–702. Available from: http://dx.doi.org/10.1016/j.berh.2014.10.018 Allen RL, O’Callaghan CA, McMichael AJ, Bowness P. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol. 1999;162(9):5045–8. Dougados M, Etcheto A, Molto A, Alonso S, Bouvet S, Daurès JP, et al. Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohort. Jt Bone Spine [Internet]. 2015;82(5):345–51. Velázquez Alejos LP, Martínez Aragón M del C, Cornejo Romero A. Extracción y purificación de ADN. Herramientas Mol Apl en Ecol. 2008;1–26. Paredes M, Galindo A, Bernal M, Avila S, Andrade D, Vergara C, et al. Analysis of the CODIS autosomal STR loci in four main Colombian regions. Forensic Sci Int. 2003;137(1):67–73. Ossa H, Manrique A, Quintanilla S, Peña A. Polimorfismos del sistema HLA (loci A *, B * y DRB1 *) en población colombiana. Nova. 2007;5(7):25–30. Garavito G, Malagón C, Ramírez LA, Cruz OFD La, Uribe O, Navarro E, et al. Polimorfismo de los alelos de los antígenos de leucocitos humanos HLA-DRB1 y su asociación con la artritis reumatoidea juvenil en una muestra de niños mestizos colombianos. Biomédica [Internet]. 2003;23(3):254–62. Available from: http://www.revistabiomedica.org/index.php/biomedica/article/view/1219 Moalic-allain V. Pièges de l ’ interprétation des anticorps anti-HLA par technologie Luminex TM Pitfalls in interpreting anti-HLA antibodies by Luminex TM technology. 2014;72(2). Tait BD, Hudson F, Brewin G, Cantwell L, Holdsworth R. Solid phase HLA antibody detection technology - Challenges in interpretation. Tissue Antigens. 2010;76(2):87–95. Morales ER. Departamento administrativo nacional de estadistica. Colombia una nacion multicultural. 2007;1–49. Arnaiz-Villena A, Juarez I, Palacio-Gruber J, Muñiz E, Campos C, Martinez-Laso J, et al. The first free Africans in America: HLA study in San Basilio de Palenque (Colombia). Hum Immunol [Internet]. 2018;79(8):585–6. Available from: https://doi.org/10.1016/j.humimm.2018.05.010 Rey D, Moscoso J, Areces C, Parga-Lozano C, Martinez-Laso J, Enriquez de Salamanca M, et al. HLA in Jaidukama: an Amerindian secluded Colombian population with new haplotypes and Asian and Pacific-shared alleles. Mol Biol Rep. 2010;38(6):3689–701. Vargas-Alarcon G, Gomez-Prieto P, Silvera C, Parga-Lozano C, Martinez-Laso J, Rey D, et al. HLA genes in Wayu Amerindians from Colombia. Immunol Invest. 2010;40(1):92–100. Vargas-alarcón G, Zuñiga GHJ, Rodríguez-pérez JM, Rangel NPC, Martínez-laso CVJ, Arnaiz-villena JGA. Distribution of HLA-B alleles in Mexican Amerindian populations. 2003;756–60. Perusco A, Gamba C, Galarza P, Rojas F, Kalapodis A, Onofri A, et al. HLA Antigenic and Haplotype Frequencies Estimated in Hematopoietic Progenitor Cell Donors From Argentina. Transplant Proc [Internet]. 2014;46(9):3064–7. Alvarez I, Bengochea M, Toledo R, Carretto E, Hidalgo PC. HLA Class I Antigen and HLA-A , -B , and -C Haplotype Frequencies in Uruguayans. 2006;78(4):513–25. M CEN, S IPH. El desplazamiento forzado en Colombia : La huella del conflicto. 2014;1–6. Gourraud PA, Pappas DJ, Baouz A, Balère ML, Garnier F, Marry E. High-resolution HLA-A, HLA-B, and HLA-DRB1 haplotype frequencies from the French Bone Marrow Donor Registry. Hum Immunol [Internet]. 2015;76(5):381–4. Arias-Murillo YR, Osorio-Arango K, Bayona B, Ercilla G, Beltrán-Durán M. Determination of HLA -A, -B, -DRB1 polymorphism in brain dead organ donors representative of the Colombian general population, 2007-2014. Biomédica [Internet]. 2017;37(2):184–90184. Varade J, Lamas JR, Ferna M, Jover JA, Ferna B, Urcelay E. HLA-B27 and ankylosing spondylitis geographic distribution versus malaria endemic : casual or causal liaison ? 2008;67(1):2–5. Mathieu A, Paladini F, Vacca A, Cauli A, Teresa M, Sorrentino R. Autoimmunity Reviews The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases : A unifying hypothesis. Autoimmun Rev [Internet]. 2009;8(5):420–5. Arnaiz-Villena A, Palacio-Grüber J, Juarez I, Hernández E, Muñiz E, Bayona B, et al. HLA in North Colombia Chimila Amerindians. Hum Immunol [Internet]. 2018;79(4):189–90. Park H, Lee YJ, Song EY, Park MH. HLA-A, HLA-B and HLA-DRB1 allele and haplotype frequencies of 10 918 Koreans from bone marrow donor registry in Korea. Int J Immunogenet. 2016;43(5):287–96. Akassou A, Yacoubi H, Jamil A, Dakka N, Amzazi S, Sadki K, et al. Prevalence of 62 HLA-B27 in Moroccan healthy subjects and patients with ankylosing spondylitis and mapping construction of several factors influencing AS diagnosis by using multiple correspondence analysis. Rheumatol Int. 2015;35(11):1889–94. Valle-Oñate R, Candia L, Romero-Sánchez C, Iglesias-Gamarra A, Caballero-Uribe C V., Santos-Moreno P, et al. Epidemiology of spondyloarthritis in Colombia. Am J Med Sci. 2011;341(4):293–4. Chaplin DD. Overview of immune response. J Allergy Clin Immunol. 2010;125:41. |
dc.rights.spa.fl_str_mv |
Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2019 |
dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-sa/4.0/ |
dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/closedAccess |
dc.rights.creativecommons.spa.fl_str_mv |
Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0) |
dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_14cb |
rights_invalid_str_mv |
Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2019 https://creativecommons.org/licenses/by-nc-sa/4.0/ Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0) http://purl.org/coar/access_right/c_14cb |
eu_rights_str_mv |
closedAccess |
dc.format.extent.spa.fl_str_mv |
75p. |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Universidad Colegio Mayor de Cundinamarca |
dc.publisher.faculty.spa.fl_str_mv |
Facultad de Ciencias de la Salud |
dc.publisher.place.spa.fl_str_mv |
Bogotá DC |
dc.publisher.program.spa.fl_str_mv |
Bacteriología y Laboratorio Clínico |
institution |
Colegio Mayor de Cundinamarca |
bitstream.url.fl_str_mv |
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/1/FRECUENCIA%20AL%c3%89LICA%20Y%20GENOTIPICA%20%20DE%20HLA-B%20Y%20%20HLA-B27%20EN%20UN%20GRUPO%20DE%20INDIVIDUOS%20SANOS%20EN%20COLOMBIA%20-3-75.pdf https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/2/DIAPOSITIVAS%20FRECUENCIA%20HLA-B.pdf https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/3/IDENTIFICACION%20TRABAJO%20DE%20GRADO.pdf https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/4/license.txt https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/5/FRECUENCIA%20AL%c3%89LICA%20Y%20GENOTIPICA%20%20DE%20HLA-B%20Y%20%20HLA-B27%20EN%20UN%20GRUPO%20DE%20INDIVIDUOS%20SANOS%20EN%20COLOMBIA%20-3-75.pdf.txt https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/7/DIAPOSITIVAS%20FRECUENCIA%20HLA-B.pdf.txt https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/9/IDENTIFICACION%20TRABAJO%20DE%20GRADO.pdf.txt https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/6/FRECUENCIA%20AL%c3%89LICA%20Y%20GENOTIPICA%20%20DE%20HLA-B%20Y%20%20HLA-B27%20EN%20UN%20GRUPO%20DE%20INDIVIDUOS%20SANOS%20EN%20COLOMBIA%20-3-75.pdf.jpg https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/8/DIAPOSITIVAS%20FRECUENCIA%20HLA-B.pdf.jpg https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/10/IDENTIFICACION%20TRABAJO%20DE%20GRADO.pdf.jpg |
bitstream.checksum.fl_str_mv |
6d3dc9fb25813d9224bf812961da527a 9f1fdb2834e1e2304caa911b56b0c7f3 43ec78f56988b3e800469778f69f3f4d 2f9959eaf5b71fae44bbf9ec84150c7a 09dd3fac4a5d1781577aa9b04ee6f706 4ad4f112905c76e76b908f4051363c57 e1c06d85ae7b8b032bef47e42e4c08f9 c1c42a79467994f856b714250019877b 76be0ab6ec22caf436a8bb75646d994b 97a2a0c134ada65b4f4c29f53731696c |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Biblioteca Digital Unicolmayor |
repository.mail.fl_str_mv |
repositorio@unicolmayor.edu.co |
_version_ |
1812210098464882688 |
spelling |
Romero Sánchez, María Consueloadef63ccda8465428682bb4b85aab02bChila Moreno, Leidy Lorena4cf9279b88e653b3ab1a8b78e5bf2628Infante Cruz, Alejandra Del Pilara7d42a491aff626fcf40c7388b25b72cHernández Bocanegra, Natalia Andreaca6fc7d8b6afea7694b18a21e26548d42021-11-22T01:48:22Z2021-11-22T01:48:22Z2019-06https://repositorio.unicolmayor.edu.co/handle/unicolmayor/369860085Varios de los genes de la respuesta inmune se encuentran en el complejo mayor de histocompatibilidad (MHC). El sistema de antígenos de leucocitos humanos (HLA) es un conjunto de moléculas de superficie de células altamente polimórficas que se unen a péptidos derivados del procesamiento antigénico con la finalidad de presentárselos a los linfocitos T, para inducir su activación y función efectora. Dentro de los alelos de clase I se encuentran el HLA-B y su subtipo HLA-B*27 que está altamente asociado con la presencia de enfermedades musculo esqueléticas. El objetivo de este proyecto de investigación es la caracterización de los genotipos y alelos HLA-B y su subtipo B*27 específicamente en una población de individuos sanos colombianos y así evidenciar la variabilidad genética producto del mestizaje. La muestra comprendió 255 individuos sanos, sin clínica sugestiva de enfermedades reumáticas, remitidos al laboratorio de Inmunología del Hospital Militar Central desde el año 2015 al 2018 con solicitud de tipificación HLA- A, B, DR por sistema molecular SSO- LUMINEX IS 100/200. Los resultados mostraron 27 genotipos y 89 alelos HLA-B, así mismo, trece sujetos fueron positivos para el antígeno B*27 correspondientes a los alelos más frecuentemente reportados en población colombiana y latinoamericana.INTRODUCCIÓN 1 1. OBJETIVOS 3 1.1. OBJETIVO GENERAL 4 1.2. OBJETIVOS ESPECÍFICOS 4 2. ANTECEDENTES 4 3. MARCO TEORICO 11 3.1. COMPLEJO MAYOR DE HISTOCOMPATIBILIDAD 11 3.2. ANTIGENO LEUCOCITARIO HUMANO HLA 12 3.3. MOLECULAS HLA 14 3.4. PROCESAMIENTO DE ANTIGENOS 16 3.4.1. Procesamiento péptidos clase I 16 3.4.2. Procesamiento de péptidos por HLA-II 21 3.5. HLA-B*27 Y ASOCIACIÓN CON ESPONDILITIS ANQUILOSANTE 24 4. DISEÑO METODOLÓGICO 26 4.1. UNIVERSO, POBLACIÓN, MUESTRA 26 4.1.1. Tipo de investigación 26 4.1.2. Población 26 4.1.3. Muestra 26 4.1.4. Selección de la muestra 26 4.1.5. Criterios de inclusión 27 4.1.6. Criterios de Exclusión 27 4.1.7. Análisis de tipificación de antígeno HLA-B 27 4.1.8. Análisis estadístico 28 4.2. HIPÓTESIS 28 4.3. TÉCNICAS Y PROCEDIMIENTOS 28 4.3.1. Extracción de DNA 28 4.3.2. Cuantificación 30 4.3.3. Amplificación por PCR 31 4.3.4. Hibridación 32 4.3.5. Tipificación HLA-B27 por técnica de Luminex IS 100/200 33 4.3.6. Secuenciación HLA de alta resolución 33 5. RESULTADOS 34 5.1. Descripción de la muestra 34 5.2. Frecuencia Genotípica del HLA -B 36 5.3. Frecuencia alélica del HLA-B 38 5.4. Frecuencia Haplotípica 41 5.5. Frecuencia HLA-B*27 42 6. DISCUSIÓN 44 7. CONCLUSIONES 51 8. REFERENCIAS 52 9. ANEXOS 63 9.1 Resultados secuenciación de alta resolución 63PregradoBacteriólogo(a) y Laboratorista Clínico75p.application/pdfspaUniversidad Colegio Mayor de CundinamarcaFacultad de Ciencias de la SaludBogotá DCBacteriología y Laboratorio ClínicoDerechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2019https://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/closedAccessAtribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)http://purl.org/coar/access_right/c_14cbFrecuencia Alélica Y Genotipica De Hla-B Y Hla-B*27 En Un Grupo De Individuos Sanos En ColombiaTrabajo de grado - Pregradohttp://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/version/c_970fb48d4fbd8a85Textinfo:eu-repo/semantics/bachelorThesishttps://purl.org/redcol/resource_type/TPinfo:eu-repo/semantics/publishedVersionAbbas A k, Lichtman AH, Pillai shiv. Inmulogía celular y molecular. 8va ed. España: Elsevier saunders; 2015. 110–130 p.Bermeo S, Guerra MT, Alfonso HO. Frecuencias de HLA-A, B y DRB1 en una población de Huila-Colombia. Rev Fac Salud - RFS. 2015;2(1):9–19.Arrunategui AM, Villegas A, Ocampo LÁ, Rodríguez LM, Badih A. Frecuencias alélicas, genotípicas y haplotípicas del sistema HLA clase I y II en donantes de una población del suroccidente colombiano. Acta Medica Colomb [Internet]. 2013;38(1):16–21.Ossa H, Aquino J, Pereira R, Ibarra A, Ossa RH, Pérez LA, et al. Outlining the ancestry landscape of Colombian admixed populations. PLoS One. 2016;11(10):1– 15.López de Castro JA. HLA-B27 y patogenia de las espondiloartropatías. Reumatol Clínica. 2009;3:S24–8.OMS C de N de la. IPD-IMGT / HLA [Internet]. IPD-IMGT / HLA. 2019.Oguz FS, Ocal L, Diler AS, Ozkul H, Asicioglu F, Kasapoglu E, et al. HLA B-27 subtypes in turkish patients with spondyloarthropathy and healthy controls. Dis Markers. 2004;20(6):309–12.Sanchez-Mazas A, Nunes JM, Middleton D, Sauter J, Buhler S, McCabe A, et al. Common and well-documented HLA alleles over all of Europe and within European sub-regions: A catalogue from the European Federation for Immunogenetics. HLA. 2017;89(2):104–13.Martínez Julio, Navarrete Ana, Arrazola Araceli, Suárez América Z-NA, Camargo Adolfo , García Beatriz RR, Ambriz Raúl JJ. Subtipos de HLA-B27 en familias de pacientes mestizos mexicanos con espondilitis anquilosante. Asoc Mex Med Transfusional, AC [Internet]. 2008;1(1):18–22.Chila M L, Romero Sánchez C, Gómez G A, Casas M, Bautista Molano W, Maldonado Z, et al. Métodos para la identificación del antígeno de histocompatibilidad HLA-B27: comparación de cuatro protocolos técnicos. Rev Med [Internet]. 2015;23(1):22.Duangchanchot M, Puapairoj C, Romphruk A, Kongmaroeng C, Leelayuwat C, 54 Romphruk A V. HLA-B*27 subtypes in Northern and Northeastern Thais, Karens, and Bamars determined by a high-resolution PCR-SSP technique. Tissue Antigens. 2009;73(6):590–4.Rodríguez LM, Giraldo MC, García N, Velásquez L, París SC, Álvarez CM, et al. Frecuencias alélicas, genotípicas y haplotípicas HLA-A, HLA-B, HLA-DRB1 en donantes fallecidos, Medellín, Colombia. Biomédica [Internet]. 2007;27(4):537.Pozzi S, Longo A, Ferrara GB. HLA-B locus sequence-based typing. Tissue Antigens. 1999;53(3):275–81.Paradoa ML, Middleton D, Acosta A, Sarmiento ME, Leyva J. Genes HLA en una muestra de la población cubana. Vaccimonitor. 2000;(3):3–7.Caraballo LR, Marrugo GJ, Erlich CH, Mildred Pastorizo L. HLA alleles in the population of Cartagena (Colombia). Tissue Antigens. 1992;39(3):128–33. 16. Bengochea M, Salzano EM. I . Alvarez M . Sans R . Toledo M . Sosa HLA Gene and Haplotype Frequencies in Uruguay. 1993;8:163–4.Infante E, Olivo A, Alaez C, Williams F, Middleton D, De la Rosa G, et al. Molecular analysis of HLA class I alleles in the Mexican Seri Indians: Implications for their origin. Tissue Antigens. 1999;54(1):35–42.Williams F, Meenagh A, Darke C, Acosta A, Daar AS, Gorodezky C, et al. Analysis of the distribution of HLA-B alleles in populations from five continents. Hum Immunol. 2001;62(6):645–50.D. Middleton, F. Williams, A. Meenagh, A. S. Daar, C. Gorodezky, M. Hammond, E. Nascimento I. Briceno and MPP. Analysis of the Distribution of HLA-A Alleles in Populations from Five Continents. Management. 2000;61(00):1048–52.Alfaro EL, Dipierri JE, Gutiérrez N, Vullo CM. Frecuencias génicas y haplotípicas del sistema HLA en el Noroeste argentino. Antropo. 2004;6(June 2014):15–23.Pédron B, Yakouben K, Guérin V, Borsali E, Auvrignon A, Landman J, et al. HLA Alleles and Haplotypes in French North African Immigrants. Hum Immunol. 2006;67(7):540–50.Zhang HB, Wei SG, Zheng HB, Yu B, Lai JH. Distribution of human leukocyte antigen alleles and haplotypes in Oroqen and Ewenki nationality minority in Inner Mongolia Autonomous Region of China. Int J Immunogenet. 2010;37(5):337–44.Acar M, Cora T, Tunc R, Acar H. HLA-B27 subtypes in Turkish patients with ankylosing spondylitis and healthy controls. Rheumatol Int. 2012;32(10):3103–5.Hajeer AH, Al Balwi MA, Ayt??l Uyar F, Alhaidan Y, Alabdulrahman A, Al Abdulkareem I, et al. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in Saudis using next generation sequencing technique. Tissue Antigens. 2013;82(4):252–8.Andric Z, Popadic D, Jovanovic B, Jaglicic I, Bojic S, Simonovic R. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in the Serbian population. Hum Immunol [Internet]. 2014;75(3):218–26.Kongmaroeng C, Romphruk A, Puapairoj C, Leelayuwat C, Kulski JK, Inoko H, et al. HLA alleles and haplotypes in Burmese (Myanmarese) and Karen in Thailand. Tissue Antigens. 2015;86(3):199–204.Sulcebe G, Shyti E. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in a population of 432 healthy unrelated individuals from Albania. Hum Immunol [Internet]. 2016;77(8):620–1.Esmaeili AR, Zamani Taghizadeh Rabe S, Mahmoudi M, Rastin M. Frequencies of HLA-A, B and DRB1 alleles in a large normal population living in the city of mashhad, northeastern Iran. Iran J Basic Med Sci. 2017;20(8):940–3.Loubser S, Paximadis M, Tiemessen CT. Human leukocyte antigen class I (A, B and C) allele and haplotype variation in a South African Mixed ancestry population. Hum Immunol [Internet]. 2017;78(5–6):399–400.Weiskopf D, Grifoni A, Arlehamn CSL, Angelo M, Leary S, Sidney J, et al. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 339 adults from Managua, Nicaragua. Hum Immunol [Internet]. 2018;79(1):1–2.Arnaiz-Villena A, Bayona B, Palacio-Gruber J, Hernández E, Muñiz E, Campos C, et al. HLA genes in Barranquilla (North Colombia): Searching for cryptic Amerindian genes. Hum Immunol [Internet]. 2018;79(1):3–4.Páez-Gutiérrez IA, Hernández-Mejía DG, Vanegas D, Camacho-Rodríguez B, Perdomo-Arciniegas AM. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies of 1463 umbilical cord blood units typed in high resolution from Bogotá Colombia. Hum Immunol [Internet]. 2019;6–11.Murphy Kenneth, Travers Paul WM. Inmunobiología de Janeway. 2009. 197–205 p.Martínez-Borra J, López-Larrea C. The emergence of the Major Histocompatilibility Complex. Adv Exp Med Biol. 2012;738:277–89.Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of the extended human MHC. Nat Rev Genet. 2004;5(12):889–99.Frank Christiansen BD. The major histocompatibility Complex: A paradigm for studies of the Human Genome. In: Immunogenetics: Methods and Applications in Clinical Practice [Internet]. 2012. p. 133–59.Claas FH, Duquesnoy RJ. The polymorphic alloimmune response in clinical transplantation. Curr Opin Immunol. 2008;20(5):566–7.Walsh EC, Stevens CR, Rioux JD, Goyette P, Vyse TJ, Fernando MMA, et al. Defining the Role of the MHC in Autoimmunity: A Review and Pooled Analysis. PLoS Genet. 2008;4(4):e1000024.Goddard CA, Butts DA, Shatz CJ. Regulation of CNS synapses by neuronal MHC class I. Proc Natl Acad Sci. 2007;104(16):6828–33.Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens. 2004;64(6):631–49.Beck S, Trowsdale J. the human major histocompatibility c omplex : Lessons from the DNA Sequence . Annu Rev Genomics Hum Genet. 2002;1(1):117–37.Centro Nacional de Información de Ciencias Médicas. CR, Morera Barrios LM, García García M de los A. Revista cubana de hematología inmunología y hemoterapia. [Internet]. Vol. 23, Revista Cubana de Hematología, Inmunología y Hemoterapia. Centro Nacional de Información de Ciencias Medicas, Ministerio de Salud Publica; 2007 [cited 2018 Oct 29]. 0–0 p.Sung C. The HLA System: Genetics, Immunology, Clinical Testing, and Clinical Implications. Yonsei Med J. 2007;48(1):11–23.Bjorkman PJ, Parham P. structure, function, and dive1rsity of class i major histOcompatibility complex molecules. 1990;Bjorman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL WD. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987;506:506–512.An J, Lein K, Kie A, Ato S. Review Articles Advances in Immunology First of Two Parts. 2000; Available from: www.nejm.orgEngelhard VH. Structure of Peptides Associated with Class I and Class II MHC Molecules. Annu Rev Immunol. 2003;12(1):181–207.Sampson C. Peptide Binding for Class I and Class II MHC Molecules. 2015;281– 302.Blum J, Wearsch P, Cresswell P. Pathways of antigen processing. Annu Rev Immunol. 2013. 443–473 p.Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, et al. MHC Molecule HLA-A2 . 1 by Mass Spectrometry. Science (80- ). 1992;255:1–4.Zimmerman SB. The three-dimensional structure of DNA. Ann Rev Biochem. 1982;51:395–427.Watts C. Capture and Processing of Exogenous Antigens for Presentation on Mhc Molecules. Annu Rev Immunol [Internet]. 1997;15(1):821–50.Wearsch PA, Cresswell P. The quality control of MHC class I peptide loading. Curr Opin Cell Biol. 2008;20(6):624–31.Cascio P, Hilton C, Kisselev AF, Rock KL, Goldberg AL. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 2001;20(10):2357–66.Nguyen TT, Chang S, Evnouchidou I, York IA, Zikos C. NIH Public Access. Nat Struct Mol Biol. 2011;18(5):604–13.Vigneron N, Ferrari V, Stroobant V, Habib JA, Van Den Eynde BJ. Peptide splicing by the proteasome. J Biol Chem. 2017;292(51):21170–9.Yewdell JW. DRiPs Solidify: Progress in Understanding Endogenous MHC Class I Antigen Processing. 2011;32(11):548–58.Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schröter F, et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell. 2010;142(4):613–24.Zarling AL, Luckey CJ, Marto JA, White FM, Brame CJ, Evans AM, et al. Tapasin Is a Facilitator, Not an Editor, of Class I MHC Peptide Binding. J Immunol [Internet]. 2003;171(10):5287–95.Concha-benavente F, Srivastava R, Ferrone S, Robert L, Hospital MG, Program I. Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells. 2017;52–8.Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature. 2002;419(6906):480– 3.Saveanu L, Carroll O, Lindo V, Del Val M, Lopez D, Lepelletier Y, et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol. 2005;6(7):689–97.Painter CA, Stern LJ. Conformational variation in structures of classical and non- classical MHCII proteins and functional implications. Immunol Rev. 2012;250(1):144–57.Anders AK, Call MJ, Schulze MSED, Fowler KD, Schubert DA, Seth NP, et al. HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat Immunol [Internet]. 2011;12(1):54–61.R. B, C.H. R, S. R, A.W. L, J.J. H, T. B, et al. Achieving stability through editing and chaperoning: Regulation of MHC class II peptide binding and expression. Immunol Rev [Internet]. 2005;207:242–60.Watts C. The endosome-lysosome pathway and information generation in the immune system. Biochim Biophys Acta - Proteins Proteomics [Internet]. 2012;1824(1):14–21.Vyas Jatin, Van der Veen Annemarthe P hidde. The known unknowns of antigen processing and presentation. 2008;8(8):607–18.Cresswell P. Invariant chain structure and MHC class II function. Cell. 1996;84(4):505–7.Piner valérie, Vergelli Marco, Martin Roland, Oddmund BAkke LE. Antigen presentation mediated by recyling of surface HLA- DR molecules. In 1995. p. 603– 6.Ghosh Partho, Amaya Miguel, Mellins Elizabeth WD. The strucutre of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Natur. 1995;378:457–62.Pos W, Sethi DK, Call MJ, Schulze MED, Anders A, Pyrdol J. Crystal Structure of the HLA-DM – HLA-DR1 Complex Defines Mechanisms for Rapid Peptide Selection. Cell [Internet]. 2012;151(7):1557–68.Castiblanco J, Anaya J-M. Genetics and Vaccines in the Era of Personalized Medicine. Curr Genomics. 2015;16(1):47–59.Maffei A, Harris PE. Peptides bound to major histocompatibility complex molecules. Peptides. 1998;19(1):179–98.Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, et al. Supporting Online Material for Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity. Publ Sci [Internet]. 2008;322(5904):1097–100.Heath WR, Carbone FR, Walter T, Hall E, Royal PO. Cross-presentation in viral immunity and self-tolerance. 2001;1(November):126–35.Kumar KS, Duesbery MS, Louat NP, Provenzano V, DiPietro MS. Microporous fine-grained copper: Structure and properties. Philos Mag A Phys Condens Matter, Struct Defects Mech Prop. 2001;81(5):1023–40.Queiro R, Morante I, Cabezas I, Acasuso B. HLA-B27 and psoriatic disease: A modern view of an old relationship. Rheumatol (United Kingdom). 2015;55(2):221– 9.Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2015;45(7):730–8.Asquith M, Elewaut D, Lin P, Rosenbaum JT. The role of the gut and microbes in the pathogenesis of spondyloarthritis. Best Pract Res Clin Rheumatol [Internet]. 2014;28(5):687–702. Available from: http://dx.doi.org/10.1016/j.berh.2014.10.018Allen RL, O’Callaghan CA, McMichael AJ, Bowness P. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol. 1999;162(9):5045–8.Dougados M, Etcheto A, Molto A, Alonso S, Bouvet S, Daurès JP, et al. Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohort. Jt Bone Spine [Internet]. 2015;82(5):345–51.Velázquez Alejos LP, Martínez Aragón M del C, Cornejo Romero A. Extracción y purificación de ADN. Herramientas Mol Apl en Ecol. 2008;1–26.Paredes M, Galindo A, Bernal M, Avila S, Andrade D, Vergara C, et al. Analysis of the CODIS autosomal STR loci in four main Colombian regions. Forensic Sci Int. 2003;137(1):67–73.Ossa H, Manrique A, Quintanilla S, Peña A. Polimorfismos del sistema HLA (loci A *, B * y DRB1 *) en población colombiana. Nova. 2007;5(7):25–30.Garavito G, Malagón C, Ramírez LA, Cruz OFD La, Uribe O, Navarro E, et al. Polimorfismo de los alelos de los antígenos de leucocitos humanos HLA-DRB1 y su asociación con la artritis reumatoidea juvenil en una muestra de niños mestizos colombianos. Biomédica [Internet]. 2003;23(3):254–62. Available from: http://www.revistabiomedica.org/index.php/biomedica/article/view/1219Moalic-allain V. Pièges de l ’ interprétation des anticorps anti-HLA par technologie Luminex TM Pitfalls in interpreting anti-HLA antibodies by Luminex TM technology. 2014;72(2).Tait BD, Hudson F, Brewin G, Cantwell L, Holdsworth R. Solid phase HLA antibody detection technology - Challenges in interpretation. Tissue Antigens. 2010;76(2):87–95.Morales ER. Departamento administrativo nacional de estadistica. Colombia una nacion multicultural. 2007;1–49.Arnaiz-Villena A, Juarez I, Palacio-Gruber J, Muñiz E, Campos C, Martinez-Laso J, et al. The first free Africans in America: HLA study in San Basilio de Palenque (Colombia). Hum Immunol [Internet]. 2018;79(8):585–6. Available from: https://doi.org/10.1016/j.humimm.2018.05.010Rey D, Moscoso J, Areces C, Parga-Lozano C, Martinez-Laso J, Enriquez de Salamanca M, et al. HLA in Jaidukama: an Amerindian secluded Colombian population with new haplotypes and Asian and Pacific-shared alleles. Mol Biol Rep. 2010;38(6):3689–701.Vargas-Alarcon G, Gomez-Prieto P, Silvera C, Parga-Lozano C, Martinez-Laso J, Rey D, et al. HLA genes in Wayu Amerindians from Colombia. Immunol Invest. 2010;40(1):92–100.Vargas-alarcón G, Zuñiga GHJ, Rodríguez-pérez JM, Rangel NPC, Martínez-laso CVJ, Arnaiz-villena JGA. Distribution of HLA-B alleles in Mexican Amerindian populations. 2003;756–60.Perusco A, Gamba C, Galarza P, Rojas F, Kalapodis A, Onofri A, et al. HLA Antigenic and Haplotype Frequencies Estimated in Hematopoietic Progenitor Cell Donors From Argentina. Transplant Proc [Internet]. 2014;46(9):3064–7.Alvarez I, Bengochea M, Toledo R, Carretto E, Hidalgo PC. HLA Class I Antigen and HLA-A , -B , and -C Haplotype Frequencies in Uruguayans. 2006;78(4):513–25.M CEN, S IPH. El desplazamiento forzado en Colombia : La huella del conflicto. 2014;1–6.Gourraud PA, Pappas DJ, Baouz A, Balère ML, Garnier F, Marry E. High-resolution HLA-A, HLA-B, and HLA-DRB1 haplotype frequencies from the French Bone Marrow Donor Registry. Hum Immunol [Internet]. 2015;76(5):381–4.Arias-Murillo YR, Osorio-Arango K, Bayona B, Ercilla G, Beltrán-Durán M. Determination of HLA -A, -B, -DRB1 polymorphism in brain dead organ donors representative of the Colombian general population, 2007-2014. Biomédica [Internet]. 2017;37(2):184–90184.Varade J, Lamas JR, Ferna M, Jover JA, Ferna B, Urcelay E. HLA-B27 and ankylosing spondylitis geographic distribution versus malaria endemic : casual or causal liaison ? 2008;67(1):2–5.Mathieu A, Paladini F, Vacca A, Cauli A, Teresa M, Sorrentino R. Autoimmunity Reviews The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases : A unifying hypothesis. Autoimmun Rev [Internet]. 2009;8(5):420–5.Arnaiz-Villena A, Palacio-Grüber J, Juarez I, Hernández E, Muñiz E, Bayona B, et al. HLA in North Colombia Chimila Amerindians. Hum Immunol [Internet]. 2018;79(4):189–90.Park H, Lee YJ, Song EY, Park MH. HLA-A, HLA-B and HLA-DRB1 allele and haplotype frequencies of 10 918 Koreans from bone marrow donor registry in Korea. Int J Immunogenet. 2016;43(5):287–96.Akassou A, Yacoubi H, Jamil A, Dakka N, Amzazi S, Sadki K, et al. Prevalence of 62 HLA-B27 in Moroccan healthy subjects and patients with ankylosing spondylitis and mapping construction of several factors influencing AS diagnosis by using multiple correspondence analysis. Rheumatol Int. 2015;35(11):1889–94.Valle-Oñate R, Candia L, Romero-Sánchez C, Iglesias-Gamarra A, Caballero-Uribe C V., Santos-Moreno P, et al. Epidemiology of spondyloarthritis in Colombia. Am J Med Sci. 2011;341(4):293–4.Chaplin DD. Overview of immune response. J Allergy Clin Immunol. 2010;125:41.frecuencia genotípicasistema LUMINEX IS 100/200HLA-BHLA-B*27frecuencia alélicaORIGINALFRECUENCIA ALÉLICA Y GENOTIPICA DE HLA-B Y HLA-B27 EN UN GRUPO DE INDIVIDUOS SANOS EN COLOMBIA -3-75.pdfFRECUENCIA ALÉLICA Y GENOTIPICA DE HLA-B Y HLA-B27 EN UN GRUPO DE INDIVIDUOS SANOS EN COLOMBIA -3-75.pdfapplication/pdf1289358https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/1/FRECUENCIA%20AL%c3%89LICA%20Y%20GENOTIPICA%20%20DE%20HLA-B%20Y%20%20HLA-B27%20EN%20UN%20GRUPO%20DE%20INDIVIDUOS%20SANOS%20EN%20COLOMBIA%20-3-75.pdf6d3dc9fb25813d9224bf812961da527aMD51open accessDIAPOSITIVAS FRECUENCIA HLA-B.pdfDIAPOSITIVAS FRECUENCIA HLA-B.pdfapplication/pdf1289114https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/2/DIAPOSITIVAS%20FRECUENCIA%20HLA-B.pdf9f1fdb2834e1e2304caa911b56b0c7f3MD52open accessIDENTIFICACION TRABAJO DE GRADO.pdfIDENTIFICACION TRABAJO DE GRADO.pdfapplication/pdf84088https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/3/IDENTIFICACION%20TRABAJO%20DE%20GRADO.pdf43ec78f56988b3e800469778f69f3f4dMD53metadata only accessLICENSElicense.txtlicense.txttext/plain; charset=utf-814828https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/4/license.txt2f9959eaf5b71fae44bbf9ec84150c7aMD54open accessTEXTFRECUENCIA ALÉLICA Y GENOTIPICA DE HLA-B Y HLA-B27 EN UN GRUPO DE INDIVIDUOS SANOS EN COLOMBIA -3-75.pdf.txtFRECUENCIA ALÉLICA Y GENOTIPICA DE HLA-B Y HLA-B27 EN UN GRUPO DE INDIVIDUOS SANOS EN COLOMBIA -3-75.pdf.txtExtracted texttext/plain129735https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/5/FRECUENCIA%20AL%c3%89LICA%20Y%20GENOTIPICA%20%20DE%20HLA-B%20Y%20%20HLA-B27%20EN%20UN%20GRUPO%20DE%20INDIVIDUOS%20SANOS%20EN%20COLOMBIA%20-3-75.pdf.txt09dd3fac4a5d1781577aa9b04ee6f706MD55open accessDIAPOSITIVAS FRECUENCIA HLA-B.pdf.txtDIAPOSITIVAS FRECUENCIA HLA-B.pdf.txtExtracted texttext/plain15468https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/7/DIAPOSITIVAS%20FRECUENCIA%20HLA-B.pdf.txt4ad4f112905c76e76b908f4051363c57MD57open accessIDENTIFICACION TRABAJO DE GRADO.pdf.txtIDENTIFICACION TRABAJO DE GRADO.pdf.txtExtracted texttext/plain2https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/9/IDENTIFICACION%20TRABAJO%20DE%20GRADO.pdf.txte1c06d85ae7b8b032bef47e42e4c08f9MD59metadata only accessTHUMBNAILFRECUENCIA ALÉLICA Y GENOTIPICA DE HLA-B Y HLA-B27 EN UN GRUPO DE INDIVIDUOS SANOS EN COLOMBIA -3-75.pdf.jpgFRECUENCIA ALÉLICA Y GENOTIPICA DE HLA-B Y HLA-B27 EN UN GRUPO DE INDIVIDUOS SANOS EN COLOMBIA -3-75.pdf.jpgGenerated Thumbnailimage/jpeg6847https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/6/FRECUENCIA%20AL%c3%89LICA%20Y%20GENOTIPICA%20%20DE%20HLA-B%20Y%20%20HLA-B27%20EN%20UN%20GRUPO%20DE%20INDIVIDUOS%20SANOS%20EN%20COLOMBIA%20-3-75.pdf.jpgc1c42a79467994f856b714250019877bMD56open accessDIAPOSITIVAS FRECUENCIA HLA-B.pdf.jpgDIAPOSITIVAS FRECUENCIA HLA-B.pdf.jpgGenerated Thumbnailimage/jpeg9293https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/8/DIAPOSITIVAS%20FRECUENCIA%20HLA-B.pdf.jpg76be0ab6ec22caf436a8bb75646d994bMD58open accessIDENTIFICACION TRABAJO DE GRADO.pdf.jpgIDENTIFICACION TRABAJO DE GRADO.pdf.jpgGenerated Thumbnailimage/jpeg7104https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/3698/10/IDENTIFICACION%20TRABAJO%20DE%20GRADO.pdf.jpg97a2a0c134ada65b4f4c29f53731696cMD510metadata only accessunicolmayor/3698oai:repositorio.unicolmayor.edu.co:unicolmayor/36982021-11-22 03:02:56.196An error occurred on the license name.|||https://creativecommons.org/licenses/by-nc-sa/4.0/open accessBiblioteca Digital Unicolmayorrepositorio@unicolmayor.edu.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 |